A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression
Open Access
- 1 November 1999
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 46 (9), 1301-1308
- https://doi.org/10.1016/s0006-3223(99)00173-0
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Do noradrenaline and serotonin differentially affect social motivation and behaviour?European Neuropsychopharmacology, 1997
- Predictors of response to amine-specific antidepressantsJournal of Affective Disorders, 1995
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- A Randomized, Double-Blind Study of Fluoxetine and Maprotiline in the Treatment of Major DepressionPharmacopsychiatry, 1991
- Randomized Double-Blind Study of Fluvoxamine and Maprotiline in Treatment of DepressionPharmacopsychiatry, 1991
- Citalopram versus maprotiline: A controlled, clinical multicentre trial in depressed patientsActa Psychiatrica Scandinavica, 1987
- Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressantActa Psychiatrica Scandinavica, 1981
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960